abc medicines limited
abc medicines limited Company Information
Company Number
09778579
Website
-Registered Address
bridge house, 25 fiddlebridge lane, hatfield, hertfordshire, AL10 0SP
Industry
Research and experimental development on biotechnology
Telephone
-
Next Accounts Due
September 2024
Group Structure
View All
Shareholders
james andrew huntington 33.3%
david john grainger 33.3%
View Allabc medicines limited Estimated Valuation
Pomanda estimates the enterprise value of ABC MEDICINES LIMITED at £78.4k based on a Turnover of £72.2k and 1.09x industry multiple (adjusted for size and gross margin).
abc medicines limited Estimated Valuation
Pomanda estimates the enterprise value of ABC MEDICINES LIMITED at £0 based on an EBITDA of £-5.6k and a 4.46x industry multiple (adjusted for size and gross margin).
abc medicines limited Estimated Valuation
Pomanda estimates the enterprise value of ABC MEDICINES LIMITED at £12.9k based on Net Assets of £25.1k and 0.51x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Abc Medicines Limited Overview
Abc Medicines Limited is a dissolved company that was located in hatfield, AL10 0SP with a Companies House number of 09778579. It operated in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in September 2015, it's largest shareholder was james andrew huntington with a 33.3% stake. The last turnover for Abc Medicines Limited was estimated at £72.2k.
Upgrade for unlimited company reports & a free credit check
Abc Medicines Limited Health Check
Pomanda's financial health check has awarded Abc Medicines Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs
3 Strong
1 Regular
6 Weak
Size
annual sales of £72.2k, make it smaller than the average company (£2.6m)
- Abc Medicines Limited
£2.6m - Industry AVG
Growth
3 year (CAGR) sales growth of 409%, show it is growing at a faster rate (11.7%)
- Abc Medicines Limited
11.7% - Industry AVG
Production
with a gross margin of 33.5%, this company has a higher cost of product (51.2%)
- Abc Medicines Limited
51.2% - Industry AVG
Profitability
an operating margin of -7.7% make it more profitable than the average company (-10%)
- Abc Medicines Limited
-10% - Industry AVG
Employees
with 1 employees, this is below the industry average (36)
- Abc Medicines Limited
36 - Industry AVG
Pay Structure
on an average salary of £66.2k, the company has an equivalent pay structure (£66.2k)
- Abc Medicines Limited
£66.2k - Industry AVG
Efficiency
resulting in sales per employee of £72.2k, this is less efficient (£108.1k)
- Abc Medicines Limited
£108.1k - Industry AVG
Debtor Days
it gets paid by customers after 129 days, this is later than average (52 days)
- Abc Medicines Limited
52 days - Industry AVG
Creditor Days
its suppliers are paid after 4 days, this is quicker than average (49 days)
- Abc Medicines Limited
49 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Abc Medicines Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Abc Medicines Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 2.2%, this is a lower level of debt than the average (42.9%)
2.2% - Abc Medicines Limited
42.9% - Industry AVG
ABC MEDICINES LIMITED financials
Abc Medicines Limited's latest turnover from September 2019 is estimated at £72.2 thousand and the company has net assets of £25.1 thousand. According to their latest financial statements, we estimate that Abc Medicines Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | |
|---|---|---|---|---|
| Turnover | ||||
| Other Income Or Grants | ||||
| Cost Of Sales | ||||
| Gross Profit | ||||
| Admin Expenses | ||||
| Operating Profit | ||||
| Interest Payable | ||||
| Interest Receivable | ||||
| Pre-Tax Profit | ||||
| Tax | ||||
| Profit After Tax | ||||
| Dividends Paid | ||||
| Retained Profit | ||||
| Employee Costs | ||||
| Number Of Employees | ||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | |
|---|---|---|---|---|
| Tangible Assets | 0 | 5,137 | 5,137 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 5,137 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 5,137 | 5,137 | 5,137 |
| Stock & work in progress | 0 | 0 | 0 | 0 |
| Trade Debtors | 25,627 | 26,081 | 26,937 | 37 |
| Group Debtors | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 28,628 |
| misc current assets | 0 | 0 | 0 | 0 |
| total current assets | 25,627 | 26,081 | 26,937 | 28,665 |
| total assets | 25,627 | 31,218 | 32,074 | 33,802 |
| Bank overdraft | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 |
| Trade Creditors | 550 | 550 | 550 | 1,438 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 |
| total current liabilities | 550 | 550 | 550 | 1,438 |
| loans | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 |
| total liabilities | 550 | 550 | 550 | 1,438 |
| net assets | 25,077 | 30,668 | 31,524 | 32,364 |
| total shareholders funds | 25,077 | 30,668 | 31,524 | 32,364 |
| Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | |
|---|---|---|---|---|
| Operating Activities | ||||
| Operating Profit | ||||
| Depreciation | 0 | 0 | ||
| Amortisation | 0 | 0 | ||
| Tax | ||||
| Stock | 0 | 0 | 0 | 0 |
| Debtors | -454 | -856 | 26,900 | 37 |
| Creditors | 0 | 0 | -888 | 1,438 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||
| Investing Activities | ||||
| capital expenditure | ||||
| Change in Investments | 0 | 0 | -5,137 | 5,137 |
| cash flow from investments | ||||
| Financing Activities | ||||
| Bank loans | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 |
| share issue | ||||
| interest | ||||
| cash flow from financing | ||||
| cash and cash equivalents | ||||
| cash | 0 | 0 | -28,628 | 28,628 |
| overdraft | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | -28,628 | 28,628 |
abc medicines limited Credit Report and Business Information
Abc Medicines Limited Competitor Analysis
Perform a competitor analysis for abc medicines limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other undefined companies, companies in AL10 area or any other competitors across 12 key performance metrics.
abc medicines limited Ownership
ABC MEDICINES LIMITED group structure
Abc Medicines Limited has 1 subsidiary company.
abc medicines limited directors
Abc Medicines Limited currently has 3 directors. The longest serving directors include Dr David Grainger (Sep 2015) and Professor James Huntington (Sep 2015).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr David Grainger | England | 57 years | Sep 2015 | - | Director |
| Professor James Huntington | United Kingdom | 59 years | Sep 2015 | - | Director |
| Dr Trevor Baglin | 66 years | Sep 2015 | - | Director |
P&L
September 2019turnover
72.2k
-9%
operating profit
-5.6k
0%
gross margin
33.6%
+4.42%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
September 2019net assets
25.1k
-0.18%
total assets
25.6k
-0.18%
cash
0
0%
net assets
Total assets minus all liabilities
abc medicines limited company details
company number
09778579
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
September 2015
age
9
incorporated
UK
accounts
Micro-Entity Accounts
ultimate parent company
previous names
N/A
last accounts submitted
September 2019
address
bridge house, 25 fiddlebridge lane, hatfield, hertfordshire, AL10 0SP
accountant
-
auditor
-
abc medicines limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to abc medicines limited.
abc medicines limited Companies House Filings - See Documents
| date | description | view/download |
|---|
